The Singapore facility is part of Sanofi's 900 million euro investment to develop two new EVFs globally over five years. The ...

Sanofi SA added a new plant in Singapore to make vaccines and other medicines, as the French pharmaceutical group seeks to ...

The 58,000 sq m plant – Sanofi’s second factory in Singapore – will produce vaccines and other biopharmaceutical products such as enzymes and lab-grown antibodies. The new facility, called Modulus, ...

Sanofi plans to phase in its own rebate model for 25 drugs — including anti-inflammatory injectable Dupixent, one of the top ...

Nov 22 (Reuters) - French drugmaker Sanofi (SASY.PA), opens new tab plans to change its policy on how it gives discounts to ...

The battle over prescription drug discounts offered to hospitals under a federal program escalated as Sanofi became the third ...

Sanofi is the third company - along with J&J and Eli Lilly - to attempt to change the way it pays for medicines under the ...

Regeneron Pharmaceuticals Inc. claims that a partner has broken a collaboration deal by refusing to reveal side deals for marketing ...

Sanofi joins Eli Lilly and Johnson & Johnson in seeking to change the 340B drug pricing program, facing pushback from HRSA and healthcare organizations.

Sanofi gets rated buy today, agreeing with bullish ratings from the Wall Street and SA analysts' consensus. With a diverse ...

The Institute for Clinical and Economic Review (ICER) has announced plans to assess the clinical efficacy and value of ...

SANOFI added a new plant in Singapore to make vaccines and other medicines, as the French pharmaceutical group seeks to ...